Clinical Trials Browser

COVID-19, Leiomyoma

NCT07328516 2026-04-16

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Enrolling by invitation

64,277 enrolled

BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Breast Neoplasms, Leukemia, Melanoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT00068003 2026-04-14

Harvesting Cells for Experimental Cancer Treatments

Enrolling by invitation

7,000 enrolled

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms

NCT00923026 2026-04-14

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

Enrolling by invitation

1,150 enrolled

DermatologicEndocrineNET

Adenocarcinoma, Carcinoma, Melanoma, Neuroendocrine Tumors

NCT00923065 2026-04-14

Data Collection, Clinical Care and Interventions in CCR, NCI

Enrolling by invitation

10,000 enrolled

Tumor-Agnostic

Neoplasms

NCT00923442 2026-04-14

Biology Studies of Hematologic Cancers

Enrolling by invitation

550 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02154022 2026-04-14

Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity

Enrolling by invitation

100 enrolled

Tumor-Agnostic

Neoplasms

NCT03226704 2026-04-14

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

Enrolling by invitation

120 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04266093 2026-04-14

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Enrolling by invitation

1,000 enrolled

GynecologicHead & Neck

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Squamous Intraepithelial Lesions of the Cervix

NCT00001620 2026-04-08

Screening for Hematology Branch Protocols

Enrolling by invitation

10,000 enrolled

Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT00027326 2026-04-08

Collection of Blood and Urine From Patients Undergoing Radiation Therapy

Enrolling by invitation

1,000 enrolled

Tumor-Agnostic

Carcinoma, Neoplasms

NCT00102544 2026-04-08

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Phase NA Enrolling by invitation

3,894 enrolled

Genitourinary

Adenocarcinoma, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Prostatic Neoplasms

NCT03762733 2026-04-08

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

Enrolling by invitation

500 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT04450927 2026-04-08

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Enrolling by invitation

10,000 enrolled

Hematologic Diseases, Neoplasms

NCT02759744 2026-04-06

Fusion Guided Focal Laser Ablation of Prostate Cancer

Phase NA Enrolling by invitation

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT03181867 2026-01-21

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Phase 2 Enrolling by invitation

800 enrolled

Genitourinary

Prostatic Neoplasms

NCT02315599 2026-01-14

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

Enrolling by invitation

500 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT02473757 2025-12-01

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Enrolling by invitation

1,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Hematologic Neoplasms

NCT05600933 2025-09-15

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Enrolling by invitation

1,200 enrolled

DermatologicGastrointestinalOther hematologic neoplasmThoracic

Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Pancreatic Neoplasms, Hematologic Neoplasms

Clinical Trials

COVID-19 Experiences in the SELF Cohort

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Harvesting Cells for Experimental Cancer Treatments

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

Data Collection, Clinical Care and Interventions in CCR, NCI

Biology Studies of Hematologic Cancers

Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Screening for Hematology Branch Protocols

Collection of Blood and Urine From Patients Undergoing Radiation Therapy

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Fusion Guided Focal Laser Ablation of Prostate Cancer

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment